IL6 and dermatomyositis: We previously reported that dermatomyositis (DM) plasma contains a higher number of EVs than healthy controls and that EVs isolated from DM plasma triggers proinflammatory cytokines (IL-6, TNFa), including type I interferon (IFN-I) release via the STING signaling pathway [10].